These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1428124)

  • 21. Functional characterization of a variant prekallikrein (PK Zürich).
    Wuillemin WA; Furlan M; von Felten A; Lämmle B
    Thromb Haemost; 1993 Sep; 70(3):427-32. PubMed ID: 8259543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of activation and autoactivation of human factor XII.
    Tankersley DL; Finlayson JS
    Biochemistry; 1984 Jan; 23(2):273-9. PubMed ID: 6607744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles.
    Griep MA; Fujikawa K; Nelsestuen GL
    Biochemistry; 1985 Jul; 24(15):4124-30. PubMed ID: 3876845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activation of prekallikrein from human blood serum by different activators].
    Iarovaia GA; Dotsenko VL; Krizhevskaia IuV; Morozova NA; Orekhovich VN
    Biokhimiia; 1979 Jul; 44(7):1279-85. PubMed ID: 497275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
    Mandle RJ; Colman RW; Kaplan AP
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dextran sulfate-dependent fibrinolysis in whole human plasma.
    Miles LA; Rothschild Z; Griffin JH
    J Lab Clin Med; 1983 Feb; 101(2):214-25. PubMed ID: 6185600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.
    Bouma BN; Griffin JH
    J Lab Clin Med; 1978 Jan; 91(1):148-55. PubMed ID: 73563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ; Dooijewaard G; Turion PN
    Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A different cleavage site for high molecular weight kininogen in vivo following intravenous injection of dextran sulfate in the rabbit.
    Wiggins RC
    Circ Res; 1986 Apr; 58(4):595-604. PubMed ID: 2421941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of HMW kininogen in surface-mediated activation of Factor XII.
    Shimada T; Sugo T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():73-85. PubMed ID: 6134440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions.
    Shibayama Y; Brunnee T; Kaplan AP; Reddigari S
    Braz J Med Biol Res; 1994 Aug; 27(8):1817-28. PubMed ID: 7749371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characterization of an abnormal factor XII molecule (F XII Bern).
    Wuillemin WA; Huber I; Furlan M; Lämmle B
    Blood; 1991 Aug; 78(4):997-1004. PubMed ID: 1868256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure, kinetics, and function of human and rhesus plasma prekallikreins are similar.
    Veloso D; Smith JI; Denny S; Cosgriff TM
    Thromb Haemost; 1992 Nov; 68(5):526-33. PubMed ID: 1455399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.